SBI Securities’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$605K Buy
6,505
+159
+3% +$15K 0.01% 380
2026
Q1
$564K Sell
6,346
-669
-10% -$68.7K 0.02% 372
2025
Q4
$668K Buy
7,015
+3,464
+98% +$349K 0.02% 337
2025
Q3
$350K Sell
3,551
-314
-8% -$33.6K 0.01% 476
2025
Q2
$412K Buy
3,865
+192
+5% +$19.4K 0.01% 406
2025
Q1
$334K Buy
3,673
+244
+7% +$27.3K 0.01% 417
2024
Q4
$391K Buy
+3,429
New +$391K 0.01% 392

Other funds holding BNTX

SBI Securities's BNTX Position: Q2 2026 in Review

SBI Securities increased its BioNTech (BNTX) stake by 2.5% in Q2 2026, buying an estimated $15K and bringing the position to 6,505 shares worth $605K. The position accounts for 0.01% of the portfolio, ranked #380.

SBI Securities first reported a position in BNTX in Q4 2024 and has held it in 7 quarters since. The position peaked at $668K in Q4 2025. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • SBI Securities held 6,505 shares of BioNTech worth $605K as of Q2 2026.
  • SBI Securities bought 159 BioNTech shares in Q2 2026, an estimated $15K.
  • BioNTech made up 0.01% of SBI Securities's portfolio in Q2 2026, its #380 holding.
  • SBI Securities first reported a position in BioNTech in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's BioNTech position peaked at $668K in Q4 2025.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.